Human EGF, Animal-Free Recombinant Protein, PeproTech

The University of Virginia awarded contract A207_PO-0435155-V3 to Life Technologies Corporation on July 18, 2026, for the procurement of specialized biological research materials. The contract, valued at ninety-two dollars, calls for the delivery of 92 units of Human Epidermal Growth Factor (EGF), Animal-Free Recombinant Protein manufactured by PeproTech, at a unit price of one dollar per unit. This product is classified as a recombinant protein reagent commonly utilized in cellular and molecular biology research applications.

Life Technologies Corporation serves as the prime contractor responsible for fulfilling delivery obligations to the University of Virginia, the contracting organization located in Virginia. The contract represents a purchase order mechanism for procurement of research-grade biological materials necessary to support the institution's scientific operations. No specific performance period or secondary performance location details beyond the University of Virginia are provided in the award documentation.